Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study

J. Li, M. Moustafa, M. Linecker, G. Lurje, I. Capobianco, J. Baumgart, F. Ratti, F. Rauchfuss, D. Balci, E. Fernandes, R. Montalti, R. Robles-Campos, B. Bjornsson, SA. Topp, J. Fronek, C. Liu, R. Wahba, C. Bruns, SM. Brunner, HJ. Schlitt, A....

. 2020 ; 27 (5) : 1372-1384. [pub] 20200130

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028188
E-zdroje Online Plný text

NLK Free Medical Journals od 1994 do Před 24 měsíci
ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2009-07-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

BACKGROUND: ALPPS is found to increase the resectability of primary and secondary liver malignancy at the advanced stage. The aim of the study was to verify the surgical and oncological outcome of ALPPS for intrahepatic cholangiocarcinoma (ICC). METHODS: The study cohort was based on the ALPPS registry with patients from 31 international centers between August 2009 and January 2018. Propensity score matched patients receiving chemotherapy only were selected from the SEER database as controls for the survival analysis. RESULTS: One hundred and two patients undergoing ALPPS were recruited, 99 completed the second stage with median inter-stage duration of 11 days. The median kinetic growth rate was 23 ml/day. R0 resection was achieved in 87 (85%). Initially high rates of morbidity and mortality decreased steadily to a 29% severe complication rate and 7% 90-day morbidity in the last 2 years. Post-hepatectomy liver failure remained the main cause of 90-day mortality. Multivariate analysis revealed insufficient future liver remnant at the stage-2 operation (FLR2) to be the only risk factor for severe complications (OR 2.91, p = 0.02). The propensity score matching analysis showed a superior overall survival in the ALPPS group compared to palliative chemotherapy (median overall survival: 26.4 months vs 14 months; 1-, 2-, and 3-year survival rates: 82.4%, 70.5% and 39.6% vs 51.2%, 21.4% and 11.3%, respectively, p < 0.01). The survival benefit, however, was not confirmed in the subgroup analysis for patients with insufficient FLR2 or multifocal ICC. CONCLUSION: ALPPS showed high efficacy in achieving R0 resections in locally advanced ICC. To get the most oncological benefit from this aggressive surgery, ALPPS would be restricted to patients with single lesions and sufficient FLR2.

1st Department of Surgery Semmelweis University Budapest Hungary

Center for Surgery and Transplantology A 1 Burnazyan Russian State Scientific Center FMBC of FMBA Moscow Russia

Centre Hépato Biliaire AP HP Hôpital Paul Brousse Inserm U 935 Univ Paris Saclay Villejuif France

Clara Campal Oncological Center Sanchinarro University Hospital San Pablo University CEU Madrid Spain

Department of General Surgery Nicosia Teaching Hospital Strovolos Cyprus

Department of General Visceral and endocrine Surgery München Klinik Neuperlach Munich Germany

Department of General Visceral and Pediatric Surgery University Hospital Düsseldorf Düsseldorf Germany

Department of General Visceral and Thoracic Surgery University Medical Center Hamburg Eppendorf Hamburg Germany

Department of General Visceral and Transplantation Surgery University Hospital Frankfurt Frankfurt Germany

Department of General Visceral and Transplantation Surgery University Hospital Mainz Mainz Germany

Department of General Visceral and Transplantation Surgery University Hospital Tuebingen Tübingen Germany

Department of General Visceral and Vascular Surgery University Hospital Jena Jena Germany

Department of General Visceral Cancer and Transplantation Surgery University Hospital of Cologne Cologne Germany

Department of Hepato Pancreato Biliary Surgery Sun Yat Sen Memorial Hospital Sun Yat Sen University Guangzhou China

Department of Human Structure and Repair Faculty of Medicine Ghent University Ghent Belgium

Department of Human Structure and Repair Faculty of Medicine Ghent University Ghent Belgium Department of Clinical Medicine and Surgery Federico 2 University Naples Italy

Department of Public Health Federico 2 University Hospital Naples Italy

Department of Surgery and Department of Clinical and Experimental Medicine Linköping University Linköping Sweden

Department of Surgery and Transplantation University Hospital RWTH Aachen Aachen Germany

Department of Surgery Ankara University Ankara Turkey

Department of Surgery Division of HPB Surgery Asklepios Hospital Barmbek Semmelweis University Budapest Campus Hamburg Hamburg Germany

Department of Surgery Federal University of Rio de Janeiro Rio de Janeiro Brazil Department of Surgery and Transplantation São Lucas Hospital Copacabana Rio de Janeiro Brazil

Department of Surgery Shinshu University School of Medicine Matsumoto Japan

Department of Surgery University College London London UK

Department of Surgery University Medical Center Regensburg Regensburg Germany

Department of Surgery Virgen de la Arrixaca Hospital IMIB Arrixaca Murcia Spain

Department of Transplant Surgery Institute for Clinical and Experimental Medicine Prague Czech Republic Department of Anatomy 2nd Faculty of Medicine Charles University Prague Czech Republic

Division of Transplantation and Hepatobiliary Surgery University of Rochester Rochester NY USA

Hepatobiliary and Abdominal Transplantation Surgery Department of Experimental and Clinical Medicine Polytechnic University of Marche Ancona Italy

Hepatobiliary Surgery and Liver Transplant Unit University of Padua Padua Italy

Hepatobiliary Surgery Division San Raffaele Hospital Milan Italy

HPB Surgery and Liver Transplant Unit Italian Hospital Buenos Aires Buenos Aires Argentina

Klinikum Karlsruhe Karlsruhe Germany

Swiss HPB and Transplantation Center Department of Surgery and Transplantation University Hospital Zurich Zurich Switzerland

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028188
003      
CZ-PrNML
005      
20210114153202.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1245/s10434-019-08192-z $2 doi
035    __
$a (PubMed)32002719
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Li, Jun $u Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. j.li@uke.de.
245    10
$a ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study / $c J. Li, M. Moustafa, M. Linecker, G. Lurje, I. Capobianco, J. Baumgart, F. Ratti, F. Rauchfuss, D. Balci, E. Fernandes, R. Montalti, R. Robles-Campos, B. Bjornsson, SA. Topp, J. Fronek, C. Liu, R. Wahba, C. Bruns, SM. Brunner, HJ. Schlitt, A. Heumann, BO. Stüben, JR. Izbicki, J. Bednarsch, E. Gringeri, E. Fasolo, J. Rolinger, J. Kristek, R. Hernandez-Alejandro, A. Schnitzbauer, N. Nuessler, MR. Schön, S. Voskanyan, AS. Petrou, O. Hahn, Y. Soejima, E. Vicente, C. Castro-Benitez, R. Adam, F. Tomassini, RI. Troisi, A. Kantas, KJ. Oldhafer, V. Ardiles, E. de Santibanes, M. Malago, PA. Clavien, M. Vivarelli, U. Settmacher, L. Aldrighetti, U. Neumann, H. Petrowsky, U. Cillo, H. Lang, S. Nadalin,
520    9_
$a BACKGROUND: ALPPS is found to increase the resectability of primary and secondary liver malignancy at the advanced stage. The aim of the study was to verify the surgical and oncological outcome of ALPPS for intrahepatic cholangiocarcinoma (ICC). METHODS: The study cohort was based on the ALPPS registry with patients from 31 international centers between August 2009 and January 2018. Propensity score matched patients receiving chemotherapy only were selected from the SEER database as controls for the survival analysis. RESULTS: One hundred and two patients undergoing ALPPS were recruited, 99 completed the second stage with median inter-stage duration of 11 days. The median kinetic growth rate was 23 ml/day. R0 resection was achieved in 87 (85%). Initially high rates of morbidity and mortality decreased steadily to a 29% severe complication rate and 7% 90-day morbidity in the last 2 years. Post-hepatectomy liver failure remained the main cause of 90-day mortality. Multivariate analysis revealed insufficient future liver remnant at the stage-2 operation (FLR2) to be the only risk factor for severe complications (OR 2.91, p = 0.02). The propensity score matching analysis showed a superior overall survival in the ALPPS group compared to palliative chemotherapy (median overall survival: 26.4 months vs 14 months; 1-, 2-, and 3-year survival rates: 82.4%, 70.5% and 39.6% vs 51.2%, 21.4% and 11.3%, respectively, p < 0.01). The survival benefit, however, was not confirmed in the subgroup analysis for patients with insufficient FLR2 or multifocal ICC. CONCLUSION: ALPPS showed high efficacy in achieving R0 resections in locally advanced ICC. To get the most oncological benefit from this aggressive surgery, ALPPS would be restricted to patients with single lesions and sufficient FLR2.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a protinádorové látky $x terapeutické užití $7 D000970
650    _2
$a ascites $x epidemiologie $7 D001201
650    _2
$a nádory žlučových cest $x chirurgie $7 D001650
650    12
$a žlučové cesty intrahepatální $7 D001653
650    _2
$a cholangiokarcinom $x chirurgie $7 D018281
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hepatektomie $x metody $7 D006498
650    _2
$a lidé $7 D006801
650    _2
$a mezinárodní spolupráce $7 D007391
650    _2
$a ligace $7 D008026
650    _2
$a selhání jater $x prevence a kontrola $7 D017093
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a paliativní péče $7 D010166
650    _2
$a vena portae $x chirurgie $7 D011169
650    _2
$a pooperační komplikace $x epidemiologie $x prevence a kontrola $7 D011183
650    _2
$a pooperační krvácení $x epidemiologie $7 D019106
650    _2
$a tendenční skóre $7 D057216
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a registrace $7 D012042
650    _2
$a program SEER $7 D018426
650    _2
$a infekce chirurgické rány $x epidemiologie $7 D013530
650    _2
$a míra přežití $7 D015996
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Moustafa, Mohamed $u Hepatobiliary Surgery and Liver Transplant Unit, University of Padua, Padua, Italy.
700    1_
$a Linecker, Michael $u Swiss HPB and Transplantation Center, Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
700    1_
$a Lurje, Georg $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Capobianco, Ivan $u Department of General, Visceral and Transplantation Surgery, University Hospital Tuebingen, Tübingen, Germany.
700    1_
$a Baumgart, Janine $u Department of General, Visceral and Transplantation Surgery, University Hospital Mainz, Mainz, Germany.
700    1_
$a Ratti, Francesca $u Hepatobiliary Surgery Division, San Raffaele Hospital, Milan, Italy.
700    1_
$a Rauchfuss, Falk $u Department of General, Visceral and Vascular Surgery, University Hospital Jena, Jena, Germany.
700    1_
$a Balci, Deniz $u Department of Surgery, Ankara University, Ankara, Turkey.
700    1_
$a Fernandes, Eduardo $u Department of Surgery, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. Department of Surgery and Transplantation, São Lucas Hospital - Copacabana, Rio de Janeiro, Brazil.
700    1_
$a Montalti, Roberto $u Department of Public Health, Federico II University Hospital, Naples, Italy.
700    1_
$a Robles-Campos, Ricardo $u Department of Surgery, Virgen de la Arrixaca Hospital, IMIB-Arrixaca, Murcia, Spain.
700    1_
$a Bjornsson, Bergthor $u Department of Surgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
700    1_
$a Topp, Stefan A $u Department of General, Visceral and Pediatric Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
700    1_
$a Fronek, Jiri $u Department of Transplant Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Liu, Chao $u Department of Hepato-Pancreato-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
700    1_
$a Wahba, Roger $u Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Bruns, Christiane $u Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Brunner, Stefan M $u Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.
700    1_
$a Schlitt, Hans J $u Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.
700    1_
$a Heumann, Asmus $u Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Stüben, Björn-Ole $u Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Izbicki, Jakob R $u Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Bednarsch, Jan $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Gringeri, Enrico $u Hepatobiliary Surgery and Liver Transplant Unit, University of Padua, Padua, Italy.
700    1_
$a Fasolo, Elisa $u Hepatobiliary Surgery and Liver Transplant Unit, University of Padua, Padua, Italy.
700    1_
$a Rolinger, Jens $u Department of General, Visceral and Transplantation Surgery, University Hospital Tuebingen, Tübingen, Germany.
700    1_
$a Kristek, Jakub $u Department of Transplant Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Hernandez-Alejandro, Roberto $u Division of Transplantation and Hepatobiliary Surgery, University of Rochester, Rochester, NY, USA.
700    1_
$a Schnitzbauer, Andreas $u Department of General, Visceral and Transplantation Surgery, University Hospital Frankfurt, Frankfurt, Germany.
700    1_
$a Nuessler, Natascha $u Department of General, Visceral and endocrine Surgery, München Klinik Neuperlach, Munich, Germany.
700    1_
$a Schön, Michael R $u Klinikum Karlsruhe, Karlsruhe, Germany.
700    1_
$a Voskanyan, Sergey $u Center for Surgery and Transplantology, A.I. Burnazyan Russian State Scientific Center FMBC of FMBA, Moscow, Russia.
700    1_
$a Petrou, Athanasios S $u Department of General Surgery, Nicosia Teaching Hospital, Strovolos, Cyprus.
700    1_
$a Hahn, Oszkar $u 1st Department of Surgery, Semmelweis University, Budapest, Hungary.
700    1_
$a Soejima, Yuji $u Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
700    1_
$a Vicente, Emilio $u "Clara Campal" Oncological Center, Sanchinarro University Hospital, San Pablo University. CEU, Madrid, Spain.
700    1_
$a Castro-Benitez, Carlos $u Centre Hépato-Biliaire, AP-HP Hôpital Paul Brousse, Inserm U 935, Univ Paris-Saclay, Villejuif, France.
700    1_
$a Adam, René $u Centre Hépato-Biliaire, AP-HP Hôpital Paul Brousse, Inserm U 935, Univ Paris-Saclay, Villejuif, France.
700    1_
$a Tomassini, Federico $u Department of Human Structure and Repair, Faculty of Medicine, Ghent University, Ghent, Belgium.
700    1_
$a Troisi, Roberto Ivan $u Department of Human Structure and Repair, Faculty of Medicine, Ghent University, Ghent, Belgium. Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
700    1_
$a Kantas, Alexandros $u Department of Surgery, Division of HPB Surgery, Asklepios Hospital Barmbek, Semmelweis University Budapest, Campus Hamburg, Hamburg, Germany.
700    1_
$a Oldhafer, Karl Juergen $u Department of Surgery, Division of HPB Surgery, Asklepios Hospital Barmbek, Semmelweis University Budapest, Campus Hamburg, Hamburg, Germany.
700    1_
$a Ardiles, Victoria $u HPB Surgery and Liver Transplant Unit, Italian Hospital Buenos Aires, Buenos Aires, Argentina.
700    1_
$a de Santibanes, Eduardo $u HPB Surgery and Liver Transplant Unit, Italian Hospital Buenos Aires, Buenos Aires, Argentina.
700    1_
$a Malago, Massimo $u Department of Surgery, University College London, London, UK.
700    1_
$a Clavien, Pierre-Alain $u Swiss HPB and Transplantation Center, Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
700    1_
$a Vivarelli, Marco $u Hepatobiliary and Abdominal Transplantation Surgery, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy.
700    1_
$a Settmacher, Utz $u Department of General, Visceral and Vascular Surgery, University Hospital Jena, Jena, Germany.
700    1_
$a Aldrighetti, Luca $u Hepatobiliary Surgery Division, San Raffaele Hospital, Milan, Italy.
700    1_
$a Neumann, Ulf $u Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
700    1_
$a Petrowsky, Henrik $u Swiss HPB and Transplantation Center, Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
700    1_
$a Cillo, Umberto $u Hepatobiliary Surgery and Liver Transplant Unit, University of Padua, Padua, Italy.
700    1_
$a Lang, Hauke $u Department of General, Visceral and Transplantation Surgery, University Hospital Mainz, Mainz, Germany.
700    1_
$a Nadalin, Silvio $u Department of General, Visceral and Transplantation Surgery, University Hospital Tuebingen, Tübingen, Germany.
773    0_
$w MED00000441 $t Annals of surgical oncology $x 1534-4681 $g Roč. 27, č. 5 (2020), s. 1372-1384
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32002719 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114153158 $b ABA008
999    __
$a ok $b bmc $g 1608523 $s 1119368
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 27 $c 5 $d 1372-1384 $e 20200130 $i 1534-4681 $m Annals of surgical oncology $n Ann Surg Oncol $x MED00000441
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...